| Hugo Gene Name |
Gene Description |
Entrez Gene | Gene Panel |
| ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | 5243 | P2 |
| ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | 5244 | P2 |
| ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | 4363 | P2 |
| ABL1 | V-abl Abelson murine leukemia viral oncogene homolog 1 | 25 | P2 |
| ABL2 | V-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) | 27 | P2 |
| ABP1 | Amiloride binding protein 1 (amine oxidase (copper-containing)) | 26 | P2 |
| ACTB | Actin, beta | 60 | P1 |
| ADAM33 | ADAM metallopeptidase domain 33 | 80332 | P2 |
| ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | 124 | P2 |
| ADH1B | Alcohol dehydrogenase IB (class I), beta polypeptide | 125 | P2 |
| ADH1C | Alcohol dehydrogenase 1C (class I), gamma polypeptide | 126 | P2 |
| ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | 127 | P2 |
| ADH5 | Alcohol dehydrogenase 5 (class III), chi polypeptide | 128 | P2 |
| ADH6 | Alcohol dehydrogenase 6 (class V) | 130 | P2 |
| ADM | Adrenomedullin | 133 | P2 |
| ADPRT | ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase) | 142 | P1 |
| ADPRTL2 | ADP-ribosyltransferase (NAD+; poly(ADP-ribose) polymerase)-like 2 | 10038 | P1 |
| AHR | Aryl hydrocarbon receptor | 196 | P1 |
| AKT2 | V-akt murine thymoma viral oncogene homolog 2 | 208 | P1 |
| ALAD | Aminolevulinate, delta-, dehydratase | 210 | P1 |
| ALDH1A1 | Aldehyde dehydrogenase 1 family, member A1 | 216 | P1 |
| ALDH1A2 | Aldehyde dehydrogenase 1 family, member A2 | 8854 | P2 |
| ANAPC10 | Anaphase promoting complex subunit 10 | 10393 | P2 |
| ANGPTL7 | Angiopoietin-like 7 | 10218 | P2 |
| AOC2 | Amine oxidase, copper containing 2 (retina-specific) | 314 | P2 |
| AOC3 | Amine oxidase, copper containing 3 (vascular adhesion protein 1) | 8639 | P2 |
| APEX | APEX nuclease (multifunctional DNA repair enzyme) | 328 | P1 |
| APEX2 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 | 27301 | P2 |
| API5 | Apoptosis inhibitor 5 | 8539 | P1 |
| APP | Amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease) | 351 | P2 |
| APRT | Adenine phosphoribosyltransferase | 353 | P1 |
| AREG | Amphiregulin (schwannoma-derived growth factor) | 374 | P1 |
| ARNT | Aryl hydrocarbon receptor nuclear translocator | 405 | P1 |
| ARSA | Arylsulfatase A | 410 | P1 |
| ASNA1 | ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial) | 439 | P1 |
| ATF3 | Activating transcription factor 3 | 467 | P1 |
| ATM | Ataxia telangiectasia mutated (includes complementation groups A, C and D) | 472 | P1 |
| ATOX1 | ATX1 antioxidant protein 1 homolog (yeast) | 475 | P2 |
| ATRX | Alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae) | 546 | P2 |
| ATXN3 | Ataxin 3 | 4287 | P2 |
| BACE1 | Beta-site APP-cleaving enzyme 1 | 23621 | P2 |
| BAK1 | BCL2-antagonist/killer 1 | 578 | P1 |
| BAX | BCL2-associated X protein | 581 | P1 |
| BCL2 | B-cell CLL/lymphoma 2 | 596 | P1 |
| BID | BH3 interacting domain death agonist | 637 | P1 |
| BIK | BCL2-interacting killer (apoptosis-inducing) | 638 | P1 |
| BIRC2 | Baculoviral IAP repeat-containing 2 | 329 | P2 |
| BIRC3 | Baculoviral IAP repeat-containing 3 | 330 | P1 |
| BIRC4 | Baculoviral IAP repeat-containing 4 | 331 | P2 |
| BIRC5 | Baculoviral IAP repeat-containing 5 (survivin) | 332 | P1 |
| BLM | Bloom syndrome | 641 | P2 |
| BLVRA | Biliverdin reductase A | 644 | P1 |
| BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | 645 | P1 |
| BNIP1 | BCL2/adenovirus E1B 19kDa interacting protein 1 | 662 | P1 |
| BNIP2 | BCL2/adenovirus E1B 19kDa interacting protein 2 | 663 | P1 |
| BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | 664 | P2 |
| BRCA1 | Breast cancer 1, early onset | 672 | P1 |
| BRCA2 | Breast cancer 2, early onset | 675 | P1 |
| BTG1 | B-cell translocation gene 1, anti-proliferative | 694 | P1 |
| BZRP | Benzodiazapine receptor (peripheral) | 706 | P1 |
| CALCA | Calcitonin/calcitonin-related polypeptide, alpha | 796 | P2 |
| CAPN1 | Calpain 1, (mu/I) large subunit | 823 | P1 |
| CAPN2 | Calpain 2, (m/II) large subunit | 824 | P1 |
| CAPN3 | Calpain 3, (p94) | 825 | P2 |
| CAPN6 | Calpain 6 | 827 | P1 |
| CAPN9 | Calpain 9 (nCL-4) | 10753 | P1 |
| CAPNS1 | Calpain, small subunit 1 | 826 | P1 |
| CASP10 | Caspase 10, apoptosis-related cysteine peptidase | 843 | P2 |
| CASP2 | Caspase 2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2) | 835 | P1 |
| CASP3 | Caspase 3, apoptosis-related cysteine protease | 836 | P1 |
| CASP4 | Caspase 4, apoptosis-related cysteine peptidase | 837 | P2 |
| CASP5 | Caspase 5, apoptosis-related cysteine peptidase | 838 | P2 |
| CASP6 | Caspase 6, apoptosis-related cysteine protease | 839 | P1 |
| CASP8 | Caspase 8, apoptosis-related cysteine peptidase | 841 | P2 |
| CASP9 | Caspase 9, apoptosis-related cysteine protease | 842 | P1 |
| CCK | Cholecystokinin | 885 | P1 |
| CCL5 | Chemokine (C-C motif) ligand 5 | 6352 | P2 |
| CCNA2 | Cyclin A2 | 890 | P1 |
| CCNB1 | Cyclin B1 | 891 | P1 |
| CCNB2 | Cyclin B2 | 9133 | P1 |
| CCND1 | Cyclin D1 (PRAD1 | 595 | P1 |
| CCND2 | Cyclin D2 | 894 | P1 |
| CCND3 | Cyclin D3 | 896 | P1 |
| CCNE1 | Cyclin E1 | 898 | P1 |
| CCNE2 | Cyclin E2 | 9134 | P1 |
| CCNG1 | Cyclin G1 | 900 | P1 |
| CCNG2 | Cyclin G2 | 901 | P1 |
| CCNH | Cyclin H | 902 | P1 |
| CCNI | Cyclin I | 10983 | P1 |
| CCNK | Cyclin K | 8812 | P1 |
| CCNT2 | Cyclin T2 | 905 | P1 |
| CCRK | Cell cycle related kinase | 23552 | P1 |
| CD3Z | CD3Z antigen, zeta polypeptide (TiT3 complex) | 919 | P2 |
| CD4 | CD4 antigen (p55) | 920 | P2 |
| CDC14A | CDC14 cell division cycle 14 homolog A (S. cerevisiae) | 8556 | P1 |
| CDC14B | CDC14 cell division cycle 14 homolog B (S. cerevisiae) | 8555 | P1 |
| CDC16 | CDC16 cell division cycle 16 homolog (S. cerevisiae) | 8881 | P1 |
| CDC2 | Cell division cycle 2, G1 to S and G2 to M | 983 | P1 |
| CDC20 | CDC20 cell division cycle 20 homolog (S. cerevisiae) | 991 | P2 |
| CDC23 | CDC23 (cell division cycle 23, yeast, homolog) | 8697 | P1 |
| CDC25A | Cell division cycle 25A | 993 | P1 |
| CDC25B | Cell division cycle 25B | 994 | P1 |
| CDC25C | Cell division cycle 25C | 995 | P1 |
| CDC27 | Cell division cycle 27 | 996 | P1 |
| CDC2L5 | Cell division cycle 2-like 5 (cholinesterase-related cell division controller) | 8621 | P1 |
| CDC34 | Cell division cycle 34 | 997 | P1 |
| CDC37 | CDC37 cell division cycle 37 homolog (S. cerevisiae) | 11140 | P2 |
| CDC42 | Cell division cycle 42 (GTP binding protein, 25kDa) | 998 | P1 |
| CDC42BPB | CDC42 binding protein kinase beta (DMPK-like) | 9578 | P2 |
| CDC42EP2 | CDC42 effector protein (Rho GTPase binding) 2 | 10435 | P1 |
| CDC45L | CDC45 cell division cycle 45-like (S. cerevisiae) | 8318 | P1 |
| CDC5L | CDC5 cell division cycle 5-like (S. pombe) | 988 | P1 |
| CDC6 | CDC6 cell division cycle 6 homolog (S. cerevisiae) | 990 | P1 |
| CDC7 | CDC7 cell division cycle 7 (S. cerevisiae) | 8317 | P1 |
| CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | 999 | P2 |
| CDK2 | Cyclin-dependent kinase 2 | 1017 | P1 |
| CDK3 | Cyclin-dependent kinase 3 | 1018 | P1 |
| CDK4 | Cyclin-dependent kinase 4 | 1019 | P1 |
| CDK5R1 | Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 8851 | P1 |
| CDK5R2 | Cyclin-dependent kinase 5, regulatory subunit 2
(p39) | 8941 | P2 |
| CDK6 | Cyclin-dependent kinase 6 | 1021 | P1 |
| CDK7 | Cyclin-dependent kinase 7 (MO15 homolog, Xenopus laevis, cdk-activating kinase) | 1022 | P1 |
| CDK9 | Cyclin-dependent kinase 9 (CDC2-related kinase) | 1025 | P1 |
| CDKL1 | Cyclin-dependent kinase-like 1 (CDC2-related kinase) | 8814 | P1 |
| CDKN1A | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 1026 | P1 |
| CDKN1B | Cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 1027 | P1 |
| CDKN2A | Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 1029 | P1 |
| CDKN2B | Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 1030 | P1 |
| CDKN2C | Cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 1031 | P1 |
| CDKN2D | Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | 1032 | P1 |
| CDKN3 | Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) | 1033 | P1 |
| CES2 | Carboxylesterase 2 (intestine, liver) | 8824 | P2 |
| CETN2 | Centrin, EF-hand protein, 2 | 1069 | P2 |
| CHC1L | Chromosome condensation 1-like | 1102 | P1 |
| CHEK1 | CHK1 checkpoint homolog (S. pombe) | 1111 | P1 |
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 11200 | P1 |
| CHRNA4 | Cholinergic receptor, nicotinic, alpha polypeptide 4 | 1137 | P2 |
| CHST1 | Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 | 8534 | P1 |
| CIZ1 | CDKN1A interacting zinc finger protein 1 | 25792 | P2 |
| CKB | Creatine kinase, brain | 1152 | P2 |
| CKN1 | Cockayne syndrome 1 (classical) | 1161 | P1 |
| CKS2 | CDC28 protein kinase 2 | 1164 | P1 |
| CLU | Clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J) | 1191 | P1 |
| COMT | Catechol-O-methyltransferase | 1312 | P1 |
| CSK | C-src tyrosine kinase | 1445 | P2 |
| CTNNA1 | Catenin (cadherin-associated protein), alpha 1, 102kDa | 1495 | P2 |
| CTNNAL1 | Catenin (cadherin-associated protein), alpha-like 1 | 8727 | P1 |
| CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | 1499 | P1 |
| CTNND1 | Catenin (cadherin-associated protein), delta 1 | 1500 | P1 |
| CTNND2 | Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein) | 1501 | P2 |
| CX3CR1 | Chemokine (C-X3-C motif) receptor 1 | 1524 | P2 |
| CXCR6 | Chemokine (C-X-C motif) receptor 6 | 10663 | P2 |
| CYC1 | Cytochrome c-1 | 1537 | P2 |
| CYP17A1 | Cytochrome P450, family 17, subfamily A, polypeptide 1 | 1586 | P2 |
| CYP19A1 | Cytochrome P450, family 19, subfamily A, polypeptide 1 | 1588 | P2 |
| CYP1A1 | Cytochrome P450, family 1, subfamily A, polypeptide 1 | 1543 | P2 |
| CYP1A2 | Cytochrome P450, family 1, subfamily A, polypeptide 2 | 1544 | P2 |
| CYP1B1 | Cytochrome P450, family 1, subfamily B, polypeptide 1 | 1545 | P1 |
| CYP27B1 | Cytochrome P450, family 27, subfamily B, polypeptide 1 | 1594 | P1 |
| CYP2A6 | Cytochrome P450, family 2, subfamily A, polypeptide 6 | 1548 | P2 |
| CYP2B6 | Cytochrome P450, family 2, subfamily B, polypeptide 6 | 1555 | P2 |
| CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | 1557 | P1 |
| CYP2C8 | Cytochrome P450, family 2, subfamily C, polypeptide 8 | 1558 | P1 |
| CYP2C9 | Cytochrome P450, family 2, subfamily C, polypeptide 9 | 1559 | P1 |
| CYP2E1 | Cytochrome P450, family 2, subfamily E, polypeptide 1 | 1571 | P2 |
| CYP2J2 | Cytochrome P450, family 2, subfamily J, polypeptide 2 | 1573 | P1 |
| CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | 1576 | P2 |
| CYP3A5 | Cytochrome P450, family 3, subfamily A, polypeptide 5 | 1577 | P2 |
| CYP4B1 | Cytochrome P450, family 4, subfamily B, polypeptide 1 | 1580 | P2 |
| CYP4V2 | Cytochrome P450, family 4, subfamily V, polypeptide 2 | 285440 | P2 |
| CYR61 | Cysteine-rich, angiogenic inducer, 61 | 3491 | P1 |
| DAD1 | Defender against cell death 1 | 1603 | P1 |
| DAP | Death-associated protein | 1611 | P1 |
| DAPK1 | Death-associated protein kinase 1 | 1612 | P2 |
| DCLRE1A | DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae) | 9937 | P1 |
| DCLRE1B | DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae) | 64858 | P2 |
| DCLRE1C | DNA cross-link repair 1C (PSO2 homolog, S. cerevisiae) | 64421 | P2 |
| DDB1 | Damage-specific DNA binding protein 1, 127kDa | 1642 | P2 |
| DDB2 | Damage-specific DNA binding protein 2, 48kDa | 1643 | P1 |
| DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | 1644 | P1 |
| DDIT3 | DNA-damage-inducible transcript 3 | 1649 | P2 |
| DEPC1 | Prostate cancer antigen-1 | 221120 | P2 |
| DIA1 | Diaphorase (NADH) (cytochrome b-5 reductase) | 1727 | P1 |
| DMC1 | DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) | 11144 | P1 |
| DNAJC3 | DnaJ (Hsp40) homolog, subfamily C, member 3 | 5611 | P1 |
| DNCH1 | Dynein, cytoplasmic, heavy polypeptide 1 | 1778 | P1 |
| DTR | Diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor) | 1839 | P1 |
| DUSP1 | Dual specificity phosphatase 1 | 1843 | P2 |
| DUT | DUTP pyrophosphatase | 1854 | P2 |
| E2F1 | E2F transcription factor 1 | 1869 | P1 |
| E2F2 | E2F transcription factor 2 | 1870 | P1 |
| E2F3 | E2F transcription factor 3 | 1871 | P1 |
| E2F4 | E2F transcription factor 4, p107/p130-binding | 1874 | P1 |
| E2F5 | E2F transcription factor 5, p130-binding | 1875 | P1 |
| ECE1 | Endothelin converting enzyme 1 | 1889 | P2 |
| EDN1 | Endothelin 1 | 1906 | P1 |
| EDN2 | Endothelin 2 | 1907 | P1 |
| EDN3 | Endothelin 3 | 1908 | P1 |
| EDNRA | Endothelin receptor type A | 1909 | P1 |
| EDNRB | Endothelin receptor type B | 1910 | P1 |
| EEF1A1 | Eukaryotic translation elongation factor 1 alpha 1 | 1915 | P1 |
| EGF | Epidermal growth factor (beta-urogastrone) | 1950 | P1 |
| EGFR | Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | 1956 | P1 |
| ELA1 | Elastase 1, pancreatic | 1990 | P1 |
| ELA2 | Elastase 2, neutrophil | 1991 | P1 |
| ENO1 | Enolase 1, (alpha) | 2023 | P2 |
| EPHX1 | Epoxide hydrolase 1, microsomal (xenobiotic) | 2052 | P1 |
| EPX | Eosinophil peroxidase | 8288 | P2 |
| ERBB2 | V-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 2064 | P1 |
| ERCC1 | Excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) | 2067 | P1 |
| ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) | 2068 | P1 |
| ERCC3 | Excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) | 2071 | P1 |
| ERCC4 | Excision repair cross-complementing rodent repair deficiency, complementation group 4 | 2072 | P1 |
| ERCC5 | Excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) | 2073 | P1 |
| ERCC6 | Excision repair cross-complementing rodent repair deficiency, complementation group 6 | 2074 | P1 |
| ESR1 | Estrogen receptor 1 | 2099 | P1 |
| ESRRA | Estrogen-related receptor alpha | 2101 | P2 |
| ESRRG | Estrogen-related receptor gamma | 2104 | P1 |
| EXO1 | Exonuclease 1 | 9156 | P1 |
| FAAH | Fatty acid amide hydrolase | 2166 | P1 |
| FADD | Fas (TNFRSF6)-associated via death domain | 8772 | P2 |
| FANCA | Fanconi anemia, complementation group A | 2175 | P1 |
| FANCC | Fanconi anemia, complementation group C | 2176 | P1 |
| FANCD2 | Fanconi anemia, complementation group D2 | 2177 | P2 |
| FANCE | Fanconi anemia, complementation group E | 2178 | P2 |
| FANCF | Fanconi anemia, complementation group F | 2188 | P2 |
| FANCG | Fanconi anemia, complementation group G | 2189 | P1 |
| FAU | Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived); ribosomal protein S30 | 2197 | P1 |
| FBP1 | Fructose-1,6-bisphosphatase 1 | 2203 | P2 |
| FDXR | Ferredoxin reductase | 2232 | P2 |
| FEN1 | Flap structure-specific endonuclease 1 | 2237 | P1 |
| FGF1 | Fibroblast growth factor 1 (acidic) | 2246 | P1 |
| FGF10 | Fibroblast growth factor 10 | 2255 | P1 |
| FGF11 | Fibroblast growth factor 11 | 2256 | P1 |
| FGF13 | Fibroblast growth factor 13 | 2258 | P1 |
| FGF17 | Fibroblast growth factor 17 | 8822 | P1 |
| FGF2 | Fibroblast growth factor 2 (basic) | 2247 | P1 |
| FGF20 | Fibroblast growth factor 20 | 26281 | P1 |
| FGF21 | Fibroblast growth factor 21 | 26291 | P2 |
| FGF22 | Fibroblast growth factor 22 | 27006 | P1 |
| FGF23 | Fibroblast growth factor 23 | 8074 | P1 |
| FGF5 | Fibroblast growth factor 5 | 2250 | P2 |
| FGF6 | Fibroblast growth factor 6 | 2251 | P1 |
| FGF8 | Fibroblast growth factor 8 (androgen-induced) | 2253 | P1 |
| FGF9 | Fibroblast growth factor 9 (glia-activating factor) | 2254 | P1 |
| FGFR1 | Fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) | 2260 | P1 |
| FGFR2 | Fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) | 2263 | P2 |
| FGFR3 | Fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) | 2261 | P1 |
| FGFR4 | Fibroblast growth factor receptor 4 | 2264 | P2 |
| FIBP | Fibroblast growth factor (acidic) intracellular binding protein | 9158 | P2 |
| FLJ35220 | Hypothetical protein FLJ35220 | 284131 | P2 |
| FMO1 | Flavin containing monooxygenase 1 | 2326 | P1 |
| FMO2 | Flavin containing monooxygenase 2 | 2327 | P2 |
| FMO3 | Flavin containing monooxygenase 3 | 2328 | P2 |
| FMO4 | Flavin containing monooxygenase 4 | 2329 | P2 |
| FMO5 | Flavin containing monooxygenase 5 | 2330 | P2 |
| FOS | V-fos FBJ murine osteosarcoma viral oncogene homolog | 2353 | P1 |
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 2354 | P2 |
| FOXM1 | Forkhead box M1 | 2305 | P2 |
| G22P1 | Thyroid autoantigen 70kDa (Ku antigen) | 2547 | P1 |
| GAB1 | GRB2-associated binding protein 1 | 2549 | P2 |
| GAD1 | Glutamate decarboxylase 1 (brain, 67kDa) | 2571 | P1 |
| GAD2 | Glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | 2572 | P1 |
| GADD45A | Growth arrest and DNA-damage-inducible, alpha | 1647 | P1 |
| GADD45B | Growth arrest and DNA-damage-inducible, beta | 4616 | P1 |
| GADD45G | Growth arrest and DNA-damage-inducible, gamma | 10912 | P1 |
| GAP43 | Growth associated protein 43 | 2596 | P1 |
| GAPD | Glyceraldehyde-3-phosphate dehydrogenase | 2597 | P1 |
| GCKR | Glucokinase (hexokinase 4) regulatory protein | 2646 | P1 |
| GCLC | Glutamate-cysteine ligase, catalytic subunit | 2729 | P1 |
| GCLM | Glutamate-cysteine ligase, modifier subunit | 2730 | P1 |
| GCSH | Glycine cleavage system protein H (aminomethyl carrier) | 2653 | P1 |
| GLP1R | Glucagon-like peptide 1 receptor | 2740 | P1 |
| GLRX | Glutaredoxin (thioltransferase) | 2745 | P2 |
| GLRX2 | Glutaredoxin 2 | 51022 | P2 |
| GPI | Glucose phosphate isomerase | 2821 | P1 |
| GPX1 | Glutathione peroxidase 1 | 2876 | P1 |
| GPX2 | Glutathione peroxidase 2 (gastrointestinal) | 2877 | P1 |
| GPX3 | Glutathione peroxidase 3 (plasma) | 2878 | P1 |
| GPX4 | Glutathione peroxidase 4 (phospholipid hydroperoxidase) | 2879 | P1 |
| GPX5 | Glutathione peroxidase 5 (epididymal androgen-related protein) | 2880 | P2 |
| GPX6 | Glutathione peroxidase 6 (olfactory) | 257202 | P2 |
| GPX7 | Glutathione peroxidase 7 | 2882 | P2 |
| GRM8 | Glutamate receptor, metabotropic 8 | 2918 | P2 |
| GSR | Glutathione reductase | 2936 | P1 |
| GSS | Glutathione synthetase | 2937 | P2 |
| GSTA3 | Glutathione S-transferase A3 | 2940 | P2 |
| GSTA4 | Glutathione S-transferase A4 | 2941 | P2 |
| GSTM2 | Glutathione S-transferase M2 (muscle) | 2946 | P2 |
| GSTM3 | Glutathione S-transferase M3 (brain) | 2947 | P2 |
| GSTP1 | Glutathione S-transferase pi | 2950 | P1 |
| GSTZ1 | Glutathione transferase zeta 1 (maleylacetoacetate isomerase) | 2954 | P1 |
| GTF2H1 | General transcription factor IIH, polypeptide 1, 62kDa | 2965 | P1 |
| GTF2H3 | General transcription factor IIH, polypeptide 3 (34kD subunit) | 2967 | P1 |
| GTF2H4 | General transcription factor IIH, polypeptide 4 (52kD subunit) | 2968 | P1 |
| H2AFX | H2A histone family, member X | 3014 | P2 |
| HCNP | HCNP protein; XPA-binding protein 2 | 56949 | P1 |
| HFE | Hemochromatosis | 3077 | P2 |
| HGF | Hepatocyte growth factor (hepapoietin A; scatter factor) | 3082 | P1 |
| HK2 | Hexokinase 2 | 3099 | P1 |
| HMOX2 | Heme oxygenase (decycling) 2 | 3163 | P1 |
| HPRT1 | Hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome) | 3251 | P1 |
| HRAS | V-Ha-ras Harvey rat sarcoma viral oncogene homolog | 3265 | P2 |
| HSD17B2 | Hydroxysteroid (17-beta) dehydrogenase 2 | 3294 | P1 |
| HSD17B3 | Hydroxysteroid (17-beta) dehydrogenase 3 | 3293 | P1 |
| HSF2 | Heat shock transcription factor 2 | 3298 | P2 |
| HSPA1A | Heat shock 70kDa protein 1A | 3303 | P2 |
| HSPA1B | Heat shock 70kDa protein 1B | 3304 | P2 |
| HSPA1L | Heat shock 70kDa protein 1-like | 3305 | P2 |
| HSPA2 | Heat shock 70kDa protein 2 | 3306 | P2 |
| HSPA5 | Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3309 | P2 |
| HSPA6 | Heat shock 70kDa protein 6 (HSP70B') | 3310 | P2 |
| HSPA9B | Heat shock 70kDa protein 9B (mortalin-2) | 3313 | P2 |
| HSPB1 | Heat shock 27kDa protein 1 | 3315 | P2 |
| HSPB2 | Heat shock 27kDa protein 2 | 3316 | P1 |
| HSU24186 | Replication protein A complex 34 kd subunit homolog Rpa4 | 29935 | P1 |
| HTATIP | HIV-1 Tat interactive protein, 60kDa | 10524 | P1 |
| HUS1 | HUS1 checkpoint homolog (S. pombe) | 3364 | P1 |
| IFNA1 | Interferon, alpha 1 | 3439 | P2 |
| IGF1 | Insulin-like growth factor 1 (somatomedin C) | 3479 | P1 |
| IGF1R | Insulin-like growth factor 1 receptor | 3480 | P1 |
| IGF2R | Insulin-like growth factor 2 receptor | 3482 | P1 |
| IGFBP1 | Insulin-like growth factor binding protein 1 | 3484 | P1 |
| IGFBP2 | Insulin-like growth factor binding protein 2, 36kDa | 3485 | P1 |
| IGFBP3 | Insulin-like growth factor binding protein 3 | 3486 | P2 |
| IGFBP4 | Insulin-like growth factor binding protein 4 | 3487 | P1 |
| IGFBP5 | Insulin-like growth factor binding protein 5 | 3488 | P1 |
| IGFBP6 | Insulin-like growth factor binding protein 6 | 3489 | P1 |
| IGFBP7 | Insulin-like growth factor binding protein 7 | 3490 | P1 |
| ITGAL | Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 3683 | P2 |
| ITM2B | Integral membrane protein 2B | 9445 | P1 |
| JUN | V-jun sarcoma virus 17 oncogene homolog (avian) | 3725 | P1 |
| JUNB | Jun B proto-oncogene | 3726 | P1 |
| JUND | Jun D proto-oncogene | 3727 | P2 |
| LCMT2 | Leucine carboxyl methyltransferase 2 | 9836 | P2 |
| LIG1 | Ligase I, DNA, ATP-dependent | 3978 | P1 |
| LIG3 | Ligase III, DNA, ATP-dependent | 3980 | P1 |
| LIG4 | Ligase IV, DNA, ATP-dependent | 3981 | |